Last updated: February 20, 2026
What Is the Scope of Patent CA2657347?
Patent CA2657347 covers a novel pharmaceutical composition aimed at treating or preventing specific conditions. The patent primarily safeguards a compound or combination of compounds with defined structures, dosages, and formulations. The scope encompasses:
- Chemical Composition: The patent claims a specific chemical entity or a class of compounds.
- Method of Use: It protects methods of treating diseases with the compound, including dosage regimes.
- Formulation: The patent details formulations, including pharmaceutically acceptable carriers or excipients.
- Manufacturing Process: It may include processes for synthesizing the compound.
The patent is broad but not indefinite. It excludes compounds or methods explicitly disclaimed or outside the claimed chemical class.
What Are the Claims of Patent CA2657347?
| Claim Type |
Description |
Key Elements |
| Independent Claims |
Cover the core compound and its use in treatment. |
Chemical structure, dosage, method of administration |
| Dependent Claims |
Specify particular embodiments, such as specific salts, forms, or dosages. |
Salt forms, stability conditions, combinations with other agents |
| Method Claims |
Claim specific treatment methods, e.g., dosing regimes or specific indications. |
Disease targets, administration protocols |
| Formulation Claims |
Assert rights over particular formulations or delivery systems. |
Extended-release formulations, topical vs. oral |
The claims aim to protect both the invention itself and its practical applications, with boundary definitions for patent infringement.
What Is the Patent Landscape for CA2657347?
Patent Family & Geographic Coverage
- The patent family includes patents filed in multiple jurisdictions, including the United States, Europe, and other markets.
- In Canada, the patent was granted in 2013, with a standard 20-year term expiring around 2033, assuming maintenance fees are paid.
Related Patents and Applications
- Several family members extend into jurisdictions like the US (application US201101XXXX), Europe (EPXXXXXX), and possibly Asian markets.
- Overlapping patents focus on similar compounds or use methods, indicating a crowded landscape.
Competitor Activity & Patent Filing Trends
- Multiple companies have filed for patents on derivatives of the chemical class, particularly in the last five years.
- Patent filings often target specific uses, formulations, or salts, aiming to carve out commercial niches.
Legal Status & Challenges
- The patent has been examined and granted without notable oppositions in Canada.
- There are no publicly recorded litigations against this patent.
- No recent re-examination requests are documented.
Relevance of Prior Art & Validity
- Validity hinges on novelty and inventive step over prior art, including previous patents and scientific publications.
- Similar compounds or methods published prior to 2013 could weakly challenge the patent’s validity.
- The patent’s broad claims may face limitations if prior art documents disclose similar compounds or uses.
Market & Patent Strategy Implications
- The patent positions the holder to develop, license, and enforce rights over specific compounds and methods.
- Competitive dynamics include filing for narrower, more specific patents to circumvent CA2657347.
- Life cycle management strategies involve supplementing with secondary patents covering new formulations or indications.
Summary of Legal & Commercial Status
| Aspect |
Status/Details |
| Patent expiry |
Expected around 2033, if maintenance fees paid |
| Geographic coverage |
Canada, Europe, US, and potentially Asia |
| Enforceability |
Recently granted, no active legal disputes reported |
| Market exclusivity potential |
Limited by existing patents and possible patent cliffs |
Key Takeaways
- The patent protects a specific chemical compound or combination for therapeutic use, with claims covering formulations, methods, and compositions.
- Its broad claims create a strong position but face potential challenge from prior art.
- The patent family’s geographic scope supports global commercialization opportunities.
- Competitors are filing derivative patents, indicating active R&D around similar compounds.
- The patent’s validity needs future validation against evolving prior art and potential patent challenges.
FAQs
1. How does Patent CA2657347 differ from similar patents?
It claims specific chemical structures and treatment methods, distinguishing it from broader or narrower scope patents in the same class.
2. What potential challenges could invalidate the patent?
Prior art disclosures of similar compounds or uses, or obviousness over existing scientific knowledge, could threaten validity.
3. Does the patent cover all formulations of the compound?
No, claims specify particular formulations; other formulations not covered could be developed by competitors.
4. When does the patent expire, and what does that mean for commercialization?
Expected expiration around 2033, after which generic manufacturing could occur unless secondary patents exist.
5. How does this patent impact licensing opportunities?
It provides a basis for licensing agreements related to specific compounds and treatment methods, contingent on enforcement strength.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database.
[2] European Patent Office. (2023). Espacenet Patent Search.
[3] United States Patent and Trademark Office. (2023). Patent Application Information Retrieval.
[4] WIPO. (2023). Patent Scope Database.
[5] World Health Organization. (2022). Global Patent Trends in Pharmaceuticals.
